View 
FILTERS (0)
* Not connected to ResearchPool

MORE FILTERS

  
reports
Carole Braudeau
  • Carole Braudeau

Morning Crédit 20/05/2024

Moody’s relève le rating d’Ontex à B2 Atos : les créanciers obligataires rejettent l’offre de Daniel Kretinsky (La Tribune)>...

Carole Braudeau
  • Carole Braudeau

Credit Morning 05/20/2024

Moody’s upgrades Ontex to B2Atos: bondholders reject Daniel Kretinsky’s offer (La Tribune)>...

Roelof-Jan van den Akker
  • Roelof-Jan van den Akker

Technical Analysis/Bund future

Mixed signals in the weekly chart shows that we are still within the bottoming process. Prices exceeded the high of the week before last week at 131.86 by making a new high at 132.06. However, last week's close at 130.69 is disappointing as it ended 19bp lower and off the highs at 132.06. This suggests that confirmation of a bottom is still required and the focus should again be on support after this weakness. Solid support in the weekly chart between 129.85 and 129.10 with the April low at 129....

Next Vision Stabilized Systems Ltd: 3 directors

Three Directors at Next Vision Stabilized Systems Ltd sold 1,245,359 shares at between 55.700ILS and 57.914ILS. The significance rating of the trade was 70/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the compa...

Agile Content S.A.: 1 director

A director at Agile Content S.A. bought 6,000 shares at 4.300EUR and the significance rating of the trade was 52/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clea...

E-Globe S.p.A: 1 director

A director at E-Globe S.p.A bought 15,000 shares at 1.424EUR and the significance rating of the trade was 52/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly ...

GPI S.p.A.: 1 director

A director at GPI S.p.A. bought 4,500 shares at 13.116EUR and the significance rating of the trade was 56/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly sho...

Peter Low
  • Peter Low

Progroup - Earnings Flash - Q1 FY 2024 Results - Lucror Analytics

Progroup reported very soft Q1/24 numbers last week, with sales down 17.1% y-o-y and EBITDA slumping 58.1% owing to lower prices. Cash flow was weak due to capex. Net leverage rose 1.2x q-o-q to 4.4x. We expect net leverage to stay elevated in the low 4x region this year, owing to EBITDA decline and cash burn. . To request full and unrestricted access to Lucror’s research and analytics platform, please visit

Marc Zwartsenburg ... (+2)
  • Marc Zwartsenburg
  • CEFA

ING Benelux Favourites/Weekly performance and valuation update

The ING Benelux Favourites list comprises ASM International, ASR, DEME Group, D'Ieteren, Fugro, OCI, Randstad and UCB.

ABGSC Healthcare Research ... (+2)
  • ABGSC Healthcare Research
  • Alexander Krämer
Stephane Foucaud
  • Stephane Foucaud

Chariot Limited (AIM: CHAR): Drilling at the second well onshore Moroc...

• Chariot has started to drill the Dartois prospect onshore Morocco. The well is targeting a different reservoir system and trapping style than the Gaufrette prospect. • The main target at Dartois is estimated to hold 12 bcf of gross prospective resources. Success would de-risk a total of 20 bcf of gross prospective resources (+8 bcf) in the Dartois area. • A rig-less well test would be run in case of success. • Our unrisked NAV for the well is £0.05 per share with a ReNAV of £0.02 per share....

Trinh Nguyen
  • Trinh Nguyen

India mustn’t skip the manufacturing train. Services alone won’t tap i...

In the past decade, India’s nominal GDP grew 80 per cent to $3.5 trillion by 2022, raising its global share by 1 percentage point to 3.5 per cent of global GDP. Such growth has lifted GDP per capita to $2,500 or by 64 per cent, thanks to government infrastructure spending on the likes of highways and renewable energy, effective disbursement of social welfare programs such as free food to 813 million people, corporate tax cut, and FDI incentives.The current account deficit (CAD) has narrowed, and...

Biokarpet S.A: 1 director

A director at Biokarpet S.A sold 165,000 shares at 2.740EUR and the significance rating of the trade was 84/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly s...

AKR Corporindo Tbk PT: 1 director

A director at AKR Corporindo Tbk PT bought 24,731,300 shares at 1,619.744IDR and the significance rating of the trade was 67/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last tw...

ABGSC Food & Beverage Research ... (+3)
  • ABGSC Food & Beverage Research
  • Benjamin Wahlstedt
  • Fredrik Ivarsson

Turning fat into fortune

Excess capacity to be filled with high-margin products. Mix improvements to drive multiple, upside risk to cons. estimates. We rate the stock BUY, TP of SEK 330 based on 24x P/E.

Colin Smith
  • Colin Smith

TheraCryf: Initiation - Strong Healing

TheraCryf is a clinical stage drug development company focused on commercialising its proprietary formulation of sulforaphane, SFX-01, and two novel drug candidates acquired in the recent Chronos transaction. The primary targets for SFX-01 are cancer and neurodevelopmental disorders while TheraCryf's new orexin and DAT programmes, extend the company's reach into neuropsychiatric drugs, currently a very active area for acquisitions and partnering. Potential target markets total in the billions of...

Loic Morvan ... (+2)
  • Loic Morvan
  • Paul Rouviere

Richemont FY24 results: jewellery continues to shine

Richemont FY24 results were broadly in line with expectations but remained solid nonetheless given good sales growth at Cartier & VCA despite a tough comparison basis, and a healthy performance in Europe and the Americas. We continue to favour Richemont as growth prospects in jewellery remain p

Loading...
New interest

Save your current filters as a new Interest

Please enter a name for this interest

Email alerts

Would you like to receive real-time email alerts when a new report is published under this interest?

Save This Search

These search results will show up under 'Saved searches' in the left panel

Please enter a name for this saved search

ResearchPool Subscriptions

Get the most out of your insights

Get in touch